Guardant Health Inc (NAS:GH)
$ 29.54 0 (0%) Market Cap: 3.61 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 52.66 GF Score: 70/100

Guardant Health Inc ECLIPSE Study Results Investor Call Transcript

Dec 15, 2022 / 10:00PM GMT
Release Date Price: $41.26 (-2.32%)
Operator

Good day, everyone, and welcome to the Guardant Health ECLIPSE results. I would now like to hand the conference over to Alex Kleban. Please go ahead, sir.

Alex Kleban

Thank you. Earlier today, Guardant Health released a readout from its ECLIPSE study. Joining me today from Guardant to discuss the results are Helmy Eltoukhy, Co-CEO; AmirAli Talasaz, co-CEO; and Mike Bell, Chief Financial Officer.

Before we begin, I'd like to remind you that during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. Additional information regarding these risks and uncertainties appears in the section entitled forward-looking statements in the press release Guardant issued today.

For a more complete [listen] description, please see the Risk Factors section of the company's annual report on Form 10-K for the year ended December 31, 2021, and in its other filings with the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot